Results 61 to 70 of about 5,927,341 (295)

Software Defined Networking (Dagstuhl Seminar 12363)

open access: yes, 2013
This report documents the talks and discussions of Dagstuhl Seminar 12363 "Software Defined Networking". The presented talks represent a spectrum of industrial and academic work as well as both technical and organizational developments surrounding ...
Koponen, Teemu, Hui, Pan
core   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Software Defined Networking: an emerging paradigm to computer networking [PDF]

open access: yes, 2017
Software Defined Networking (SDN) is an emerging paradigm in networking technology that enables innovation on how network systems are managed and designed. SDN plays a huge role in the effort to make computer networks programmable.
Oladunjoye, Olanrewaju
core  

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Seamless handover in software-defined satellite networking [PDF]

open access: yes, 2016
Satellites have largely been designed as application specific and isolated for the past decades. Though with certain benefits, it might lead to resource under utilization and limited satellite applications.
Chu, X., Song, G., Yang, B., Wu, Y.
core   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

State of the art in software defined networking (SDN)

open access: yesVisión Electrónica, 2019
The growth of networks at a global level is inevitable due to the increase of users, devices and applications, such as: Internet of Things (IoT), processing and analysis of large amounts of information (Big Data), or streaming audio and video, which has ...
Miguel Ángel Barrera Pérez   +3 more
doaj   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Mobility-aware Software-Defined Service-Centric Networking

open access: yes, 2022
Future Internet applications, such as the vehicular use cases, impose requirements that challenge current networking paradigms. Hence, other networking paradigms have been proposed, such as Software-Defined Networking (SDN) and Information-Centric ...
Braun, Torsten   +3 more
core   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy